bm 13505 has been researched along with sphingosine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blum, A; Bohle, RM; Buerke, M; Fink, L; Grandel, U; Grimminger, F; Heep, M; Kraemer, HJ; Mayer, K; Seeger, W; Sibelius, U | 1 |
1 other study(ies) available for bm 13505 and sphingosine
| Article | Year |
|---|---|
Endotoxin-induced myocardial tumor necrosis factor-alpha synthesis depresses contractility of isolated rat hearts: evidence for a role of sphingosine and cyclooxygenase-2-derived thromboxane production.
Topics: Animals; Capillary Permeability; Creatine Kinase; Cyclooxygenase 2; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; Epoprostenol; Ethanolamines; Gene Expression Regulation; Heart; Immune Sera; In Vitro Techniques; Indomethacin; Isoenzymes; L-Lactate Dehydrogenase; Lipopolysaccharides; Myocardial Contraction; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrobenzenes; Oleic Acids; Phenylacetates; Prostaglandin-Endoperoxide Synthases; Rats; RNA, Messenger; Sphingosine; Sulfonamides; Thromboxane A2; Thromboxanes; Tumor Necrosis Factor-alpha | 2000 |